pharma · Hepatitis B · Mixed Dyslipidemia · ARWR
Arrowhead Pharmaceuticals Ireland
Arrowhead Pharmaceuticals Ireland Limited
NovaPharmaNews editorial coverage mentioning Arrowhead Pharmaceuticals Ireland — regulatory, clinical, and market analysis.
Company details
- Status
- Public
- HQ
- 177 E Colorado Blvd, Suite 700, Pasadena, California 91105, US
- Employees
- 746
- Programs
- 63
- Drugs
- 34
- Patents
- 126
News & analysis
NovaPharmaNews articles mentioning Arrowhead Pharmaceuticals Ireland — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning Arrowhead Pharmaceuticals Ireland — regulatory, clinical, and market analysis.
Arrowhead Pharmaceuticals Presents Positive Cardiometabolic Data at European A Meeting
Arrowhead Pharmaceuticals has presented new positive clinical data for its cardiometabolic disorder program at the 94th European A meeting. This development could significantly impact the competitive landscape and presents potential opportunities for pharmaceutical business development teams.
Arrowhead Pharmaceuticals to Participate in Key June 2026 Industry Events
Arrowhead Pharmaceuticals is set to participate in several key industry events throughout June 2026. These appearances provide a crucial opportunity for analysts, strategy, and business development teams to gain insights into the company's pipeline advancements and strategic direction.